Active	Status	Sponsor type	Region	Phase	Filter
4 Active 1 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
BURTEY, Stéphane
GOOD-IDES-02, NCT05679401: A Study With Imlifidase in Anti-GBM Disease	Active, not recruiting	3	50	Europe, US, RoW	Imlifidase, IdeS, HMED-IdeS, Plasma exchange (PLEX), PE, Cyclophosphamide (CYC), Glucocorticoids	Hansa Biopharma AB	Anti-Glomerular Basement Membrane Disease, Anti-Glomerular Basement Membrane Antibody Disease, Goodpasture Syndrome, Good Pasture Syndrome	06/25	11/26
TRACK, NCT03969953 / 2020-000334-17: Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease Jan 2025 - Dec 2025: From TRACK trial for cardiovascular disease in chronic kidney disease	Recruiting	3	2000	Europe, Canada, RoW	Rivaroxaban 2.5 Mg Oral Tablet, Xarelto, Placebo	The George Institute, George Clinical Pty Ltd, Bayer, Centre Hospitalier Régional Universitaire de Nancy, King Abdullah International Medical Research Center	Chronic Kidney Diseases, Dialysis-dependent Kidney Failure, Cardiovascular Disease	06/27	12/27
NCT05489120: Low-Protein Diet with Low-Protein Foods Versus a LPD Without LP Foods in Patients with Chronic Kidney Disease (CKD)	Recruiting	N/A	244	Europe	Consumption of FLAVIS	Dr. Schär AG / SPA, Slb Pharma	Chronic Kidney Disease Stage 3B, Chronic Kidney Disease Stage4, Chronic Kidney Disease Stage 5, Chronic Kidney Disease Stage 3A	03/26	03/26
Nelveg-Kristensen, Karl E
GOOD-IDES-02, NCT05679401: A Study With Imlifidase in Anti-GBM Disease	Active, not recruiting	3	50	Europe, US, RoW	Imlifidase, IdeS, HMED-IdeS, Plasma exchange (PLEX), PE, Cyclophosphamide (CYC), Glucocorticoids	Hansa Biopharma AB	Anti-Glomerular Basement Membrane Disease, Anti-Glomerular Basement Membrane Antibody Disease, Goodpasture Syndrome, Good Pasture Syndrome	06/25	11/26